Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1775 with Gemcitabine and Radiation in Pancreatic Cancer
NCT02037230Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jan 2014
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in pancreatic adenocarcinoma (PDAC), sponsored by University of Michigan Rogel Cancer Center. Started Jan 2014; status: completed.
02
Drugs
adavosertib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02037230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037230.